chemistry

Taletrectinib

Taletrectinib is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Taletrectinib rather than just read about it. In short: Taletrectinib, sold under the brand name Ibtrozi, is an anti-cancer medication used for the treatment of non-small cell lung cancer. It is used as the salt, taletrectinib adipate.

Key takeaways

Taletrectinib belongs to chemistry; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Taletrectinib to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Taletrectinib from memory before moving on to harder problems.

Reference excerpt

Taletrectinib, sold under the brand name Ibtrozi, is an anti-cancer medication used for the treatment of non-small cell lung cancer. It is used as the salt, taletrectinib adipate. Taletrectinib is a kinase inhibitor. It is taken by mouth. Taletrectinib was approved for medical use in the United States in June 2025.

Medical uses Taletrectinib is indicated for the treatment of adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer.

Adverse effects The US Food and Drug Administration (FDA) prescribing information for taletrectinib includes warnings and precautions for hepatotoxicity, interstitial lung disease/pneumonitis, QTc interval prolongation, hyperuricemia, myalgia with creatine phosphokinase elevation, skeletal fractures, and embryo-fetal toxicity.

History The US Food and Drug Administration (FDA) approved taletrectinib based on evidence from 270 participants with ROS1-positive NSCLC that had spread beyond the lungs who received taletrectinib 600 mg orally once daily, enrolled in two clinical trials: TRUST-I (NCT04395677) or TRUST-II (NCT04919811). The TRUST-I trial was conducted exclusively in China and the TRUST-II trial was conducted globally in North America (United States and Canada), Europe (France, Italy, Spain, and Poland), and Asia (China, Japan, and South Korea). The efficacy of taletrectinib to treat ROS1-positive non-small cell lung cancer was evaluated in participants with locally advanced or metastatic, ROS1-positive non-small cell lung cancer enrolled in two multi-center, single-arm, open-label clinical trials, TRUST-I (NCT04395677) and TRUST-II (NCT04919811). The efficacy population included 157 participants (103 in TRUST-I; 54 in TRUST-II) who were naïve to treatment with a ROS1 tyrosine kinase inhibitor (TKI) and 113 participants (66 in TRUST-I; 47 in TRUST-II) who had received one prior ROS1 tyrosine kinase inhibitor. Participants may have received prior chemotherapy for advanced disease. The safety of taletrectinib was evaluated in 352 participants (337 with non-small cell lung cancer and 15 with other solid tumors) who received at least one 600 mg dose of taletrectinib. In the 337 participants with non-small cell lung cancer, the median age was 56 years (range: 26 to 83); 56% female; 76% Asian, 15% White, 0.6% Black or African American, 8% unknown or other races; and 1.8% were of Hispanic or Latino ethnicity. The number of participants representing efficacy findings differs from the number of participants representing safety findings due to different groups of study participants analyzed for efficacy and safety. The FDA granted the application for taletrectinib priority review, breakthrough therapy, and orphan drug designations.

Society and culture

Legal status Taletrectinib was approved for medical use in the United States in June 2025.

Names Taletrectinib is the international nonproprietary name. Taletrectinib is sold under the brand name Ibtrozi.

References

External links Clinical trial number NCT04395677 for "A Study of AB-106 in Subjects With Advanced NSCLC Harboring ROS1 Fusion Gene" at ClinicalTrials.gov Clinical trial number NCT04919811 for "Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC (TRUST-II)" at ClinicalTrials.gov

Illustrations

Worked examples

Example 1 — a first encounter with Taletrectinib

Start with the simplest possible case. Write down what Taletrectinib claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Taletrectinib before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Taletrectinib ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Taletrectinib

In research: Taletrectinib appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Taletrectinib in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Taletrectinib is common in secondary-school and first-year university syllabi. It links to neighbouring topics 3-Fluorophenyl compounds, Antineoplastic and immunomodulating drug stubs, Drugs not assigned an ATC code, so understanding it makes those chapters shorter.
In everyday life: Look for Taletrectinib outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Taletrectinib” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Taletrectinib in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Taletrectinib means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Taletrectinib out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Taletrectinib in simple terms?

Taletrectinib, sold under the brand name Ibtrozi, is an anti-cancer medication used for the treatment of non-small cell lung cancer. It is used as the salt, taletrectinib adipate.

Why does Taletrectinib matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Taletrectinib?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Taletrectinib.